Biotech RadarJobs updated

COMPANY

Vividion Therapeutics

HQ: San Diego, CA source · vividion.com ↗ · West Coast

Status: Acquired, now part of Bayer · How status works

Clinical Phase 2

7 open jobs · last seen Oct 23, 2026 · 5 sources

Keywords: small molecule Colorectal Cancer Colorectal Adenocarcinoma Advanced Hematologic Tumors VVD-133214 VVD-130850 VVD-130037 VVD-159642

Profile checked Oct 10, 2026

7Open jobs5Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Associate Director/Director/Senior Director, Clinical BiomarkersSan DiegoOct 5, 2026Oct 11, 2026
Associate Scientist, Preformulation Sciences (Contractor)San DiegoOct 2, 2026Oct 11, 2026
Senior Associate Scientist, Translational Research (Contractor)San DiegoOct 2, 2026Oct 11, 2026
Associate Director, AccountingSan DiegoSep 11, 2026Oct 11, 2026
Vice President, Product Team LeaderSan DiegoSep 11, 2026Oct 11, 2026

See all 7 jobs

Timeline

  1. Trial start Phase 2: A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum source ↗
  2. Trial start Phase 1: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors source ↗
  3. Trial start Phase 1: A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors source ↗
  4. Trial start Phase 1: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors source ↗
  5. Trial start Phase 1: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 5

RecordTitlePhaseStatusStartPrimary completion
NCT06004245A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid TumorsPhase 1RecruitingJan 25, 2024May 31, 2027 (estimated)
NCT07811193A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or RectumPhase 2RecruitingSep 11, 2026Jun 30, 2028 (estimated)
NCT06188208A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic TumorsPhase 1TerminatedJan 5, 2024Feb 20, 2026 (actual)
NCT05954312A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid TumorsPhase 1RecruitingJul 28, 2023Aug 31, 2030 (estimated)
NCT06804824A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid TumorsPhase 1RecruitingFeb 25, 2025Aug 1, 2027 (estimated)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Open jobs 7

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Associate Director/Director/Senior Director, Clinical BiomarkersSan DiegoOct 5, 2026Oct 11, 2026Senior
Associate Scientist, Preformulation Sciences (Contractor)San DiegoOct 2, 2026Oct 11, 2026Mid
Senior Associate Scientist, Translational Research (Contractor)San DiegoOct 2, 2026Oct 11, 2026Mid
Associate Director, AccountingSan DiegoSep 11, 2026Oct 11, 2026Senior
Vice President, Product Team LeaderSan DiegoSep 11, 2026Oct 11, 2026Executive
Principal Scientist, Chemical DevelopmentSan DiegoSep 9, 2026Oct 11, 2026Senior
Senior Scientist / Principal Scientist / Associate Director, BiotransformationSan DiegoSep 4, 2026Oct 11, 2026Senior

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Connect

See your connections at Vividion Therapeutics on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18

Feedback